Using Caenorhabditis elegans for antimicrobial drug discovery

Author： Desalermos Athanasios   Muhammed Maged   Glavis-Bloom Justin   Mylonakis Eleftherios  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.6, 2011-06, pp. : 645-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CAENORHABDITIS ELEGANS AS AN ALTERNATIVE ANIMAL SPECIES

By Williams Phillip L.   Anderson Gary L.   Johnstone John L.   Nunn Adrian D.   Tweedle Michael F.   Wedeking Paul  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 8, 2000-12 ,pp. : 641-647

Taylor & Francis Ltd

Access to resources Recommend Favorite

Toxicity of 7-Ketocholesterol on Lethality, Growth, Reproduction, and Germline Apoptosis in the Nematode Caenorhabditis elegans

By          

Journal of Toxicology and Environmental Health, Vol. 77, Iss. 12, 2014-06 ,pp. : 716-723

Taylor & Francis Ltd

Access to resources Recommend Favorite

Dispersed crude oil amplifies germ cell apoptosis in Caenorhabditis elegans, followed a CEP-1-dependent pathway

By Polli Joseph   Zhang Yanqiong   Pan Xiaoping  

Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. : 543-551

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic target discovery using Caenorhabditis elegans

By Link Elizabeth M   Hardiman Gary   Sluder Ann E   Johnson Carl D   Liu Leo X  

Pharmacogenomics, Vol. 1, Iss. 2, 2000-05 ,pp. : 203-217

Future Medicine

Access to resources Recommend Favorite

Caenorhabditis elegans-based Model Systems for Antifungal Drug Discovery

By  

Current Pharmaceutical Design, Vol. 17, Iss. 13, 2011-05 ,pp. : 1225-1233

Bentham Science Publishers

Access to resources Recommend Favorite